Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$72,266,858
+$11,328,666 QoQ
Shares Held
562,388
+11.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#252
of 3,769 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026&PARTNERS holds $840,453,680 across 15 Drug Manufacturers - General names. MRK ranks #5 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
180,745 | $216,790,993 | |
| 2 | JNJ |
Johnson & Johnson
|
809,873 | $205,683,445 | |
| 3 | ABBV |
AbbVie Inc.
|
425,683 | $107,118,870 | |
| 4 | AMGN |
Amgen Inc
|
280,838 | $101,697,056 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
562,388 | $72,266,858 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
403,145 | $50,933,339 | |
| 7 | NVS |
Novartis AG
|
147,424 | $23,104,289 | |
| 8 | AZN |
Astrazeneca PLC
|
99,983 | $18,958,776 |
All Filings in MRK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72,266,858 | 562,388 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $60,938,192 | 506,594 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $53,040,514 | 503,900 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $39,483,693 | 470,436 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $35,469,854 | 448,078 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $45,039,683 | 501,779 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $41,901,473 | 421,205 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $27,017,854 | 237,917 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,293,778 | 91,226 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $3,731,414 | 28,279 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $2,052,519 | 18,827 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $909,254 | 8,832 | Shares | Sole | 2023-10-06 | |
| 2023-06-30 | $986,122 | 8,546 | Shares | Sole | 2023-07-05 | |
| 2023-03-31 | $918,358 | 8,632 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $1,040,821 | 9,381 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $951,539 | 11,049 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $1,030,129 | 11,299 | Shares | Sole | 2022-07-06 | |
| 2022-03-31 | $805,238 | 9,814 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $325,183 | 4,243 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $299,914 | 3,993 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $310,535 | 3,993 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $238,439 | 3,093 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $253,007 | 3,093 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $236,905 | 2,856 | Shares | Sole | 2020-10-05 | |
| No filing history on record for this holder in this stock. | ||||||